Cytogenetic analyses of three patients during autopsy who had a pathologic diagnosis of malignant histiocytosis and of one patient who was strongly suspected to have malignant histiocytosis because of her clinical and hematologic findings were done. All three patients studied with bone marrow specim
Chromosome abnormalities in malignant histiocytosis
โ Scribed by Yasuhiko Kaneko; Masahiro Kikuchi; Akinori Ishihara; Rokuo Abe; Shojiro Takayama; Masaharu Sakurai
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 939 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Chromosome and pathologic studies were performed on two patients (a 12-year-old boy and a 62-yearold woman) with malignant histiocytosis (MH). Both patients had chromosome abnormalities in their neoplastic cells: the boy's karyotype was 45,Xp+,-Y,9p+,18q-, and the woman's 48,XX+16, inv( l),mar(5),6p-,IOp+,l tq+,i(lh),+i( 18s). The boy had typical clinical and pathologic findings of MH, and died without achieving remission by chemotherapy. At the initial stage the woman had the clinical and hematologic findings of MH. Chemotherapy was given, but had no beneficial effects. At the terminal stage the bone marrow (BM) biopsy and aspirate, and the autopsy findings, were consistent with those of non-Hodgkin lymphoma, diffuse large cell type, although some histiocytes or abnormal cells in monocyte-macrophage lineage remained in the BM and the autopsied lymph nodes. This study and a review of data on six other cases have failed to establish any specific chromosome changes in MH.
Cancer 56:144-151, 1985.
ALIGNANT HIsTiocYTosis (MH), also referred to M as histiocytic medullary reticulosis (HMR), is a systemic disease characterized by diffuse neoplastic proliferation of histiocytes and their precursors in various tissues including lymph nodes (LNs), bone marrow (BM), liver, and spleen.'-3 MH is considered to be a heterogeneous group of diseases in regard to the clinical course as well as the response to chem~therapy.~.' Chromosome studies on leukemia and lymphoma have been done extensively, and have provided essential information regarding their biologic nature and classification! Data on chromosomes in MH, however, are Here, we describe the chromosome findings as well as the clinical, hematologic, and pathologic features in two patients with MH. We also summarize the chromosome pattern in MH from our cases and those in the l i t e r a t ~r e . ~-~
๐ SIMILAR VOLUMES
Chromosome 1 abnormalities are the most commonly detected aberrations in many cancers including malignant melanomas. Specific breakpoints are reported for malignant melanomas throughout the chromosome but especially at 1p36 and at several sites throughout 1p22-q21. In addition, partial deletions and
Twenty-six patients who had cytogenetic analyses performed for myeloid malignancies at St. Vincent's Hospital over a 6-year period were found to have an inversion abnormality of chromosome 16 (25 patients) or t(16;16) (1 patient). Only 16 patients had all the features of M4Eo, while the other 10 pat
Malignant histiocytosis (MH) is a distinct disease entity defined clinically and morphologically. However, the neoplastic origin of MH is not well established. The authors report a 26-year-old woman who showed the typical clinicopathologic features of so-called MH. Cytogenetic and molecular genetic
Erythroleukemia (EL) is a heterogeneous disease in terms of cell type affected, chromosome abnormalities found in the malignant clone, and clinical course. In this article, cases of erythroid EL from the recent medical literature are reviewed using cytogenetic criteria to distinguish such cases from